TDC
ETRM

Thompson Davis & Co’s EnteroMedics Inc. ETRM Stock Holding History

Thompson Davis & Co’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21
Closed -$3K – 1293
2015
Q4 		$3K Sell
21
-4
-16% -$829 ﹤0.01% 1002
2015
Q3 		$7K Sell
25
-15
-38% -$4.79K 0.01% 785
2015
Q2 		$26K Sell
40
-10
-20% -$11.5K 0.03% 480
2015
Q1 		$48K Buy
+50
New +$60.3K 0.06% 302

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Thompson Davis & Co's ETRM Position: Q1 2016 in Review

Thompson Davis & Co sold out of EnteroMedics Inc. (ETRM) in Q1 2016, closing a stake of 21 shares — an estimated $3K sold.

Thompson Davis & Co first reported a position in ETRM in Q1 2015 and held it in 4 quarters. The position peaked at $48K in Q1 2015. 26 funds tracked by Wall St. Rank hold ETRM as of Q1 2016.

  • Thompson Davis & Co reported no remaining EnteroMedics Inc. position as of Q1 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 21 EnteroMedics Inc. shares in Q1 2016, an estimated $3K.
  • Thompson Davis & Co first reported a position in EnteroMedics Inc. in Q1 2015 and held it in 4 quarters.
  • Thompson Davis & Co's EnteroMedics Inc. position peaked at $48K in Q1 2015.
  • 26 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2016.

Based on Thompson Davis & Co's 13F filing for Q1 2016, filed 2 May 2016.